Latest news
Is Repligen’s (RGEN) Rising Revenue But Softer Earnings Rewriting Its Profitability Story? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 18:30:39 GMTRepligen: Acquisition To Add Cell Therapy Capabilities (NASDAQ:RGEN) - Seeking AlphaSeeking Alpha · Sun, 02 Aug 2026 15:50:56 GMTWhy Repligen (RGEN) Is Up 6.9% After Mixed Q2 2026 Results With Higher Revenue And Lower EPS - simplywall.stsimplywall.st · Sat, 01 Aug 2026 09:35:49 GMTAnalysts Offer Insights on Healthcare Companies: Repligen (RGEN) and Envista Holdings (NVST) - The Globe and MailThe Globe and Mail · Thu, 30 Jul 2026 11:46:00 GMTRepligen Beats Q2 Earnings Estimates, Raises 2026 View, Stock Up - The Globe and MailThe Globe and Mail · Wed, 29 Jul 2026 17:38:00 GMTWhy Repligen (RGEN) Stock Is Up Today - StockStoryStockStory · Tue, 28 Jul 2026 19:40:35 GMTRepligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT